Serum Fibulin-5, VEGF-C, and selenium-binding protein-1 levels across stages of diabetic retinopathy: An observational study on pathophysiological associations
International Journal of Medical Biochemistry · 2026 · 111-116
DOI: 10.14744/ijmb.2026.87360 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Biochemistry, 2026. Verfasst von Muhammed Selman Arslan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
D iabetic retinopathy (DR) is a major microvascular compli- cation of diabetes mellitus and remains one of the leading causes of vision loss worldwide [1].The global prevalence of DR is increasing in parallel with the rise in diabetes, posing a significant public health problem.The International Diabetes Federation has estimated that the number of DM patients worldwide will increase from 463 million in 2019 to 700 million by 2045 [2].Similarly, it is estimated that the global prevalence of DR will rise significantly, reaching approximately 160.5 million by 2045 [3].DR is classified into non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) [4].NPDR, the early stage, is characterized by microaneurysms, hemorrhages, and exudates.Over time, it may progress to PDR, which involves pathological neovascularization and carries a high risk of severe vision loss.The pathophysiology involves hyperglycemia-induced endothelial dysfunction, oxidative stress, inflammation, and extracellular matrix (ECM) remodeling [5,6].
Objectives
Diabetic retinopathy (DR) is a major microvascular complication of diabetes characterized by vascular instability and oxidative stress.This study aimed to evaluate the serum levels of Fibulin-5, Selenium-Binding Protein-1 (SBP-1), and Vascular Endothelial Growth Factor-C (VEGF-C) across different clinical stages of DR and to investigate their independent pathophysiological associations.
Methods
This cross-sectional study included 179 participants categorized into four groups: healthy controls (n=45), diabetes mellitus (DM) without retinopathy (n=45), non-proliferative DR (NPDR) (n=45), and proliferative DR (PDR) (n=44).Serum levels were measured using ELISA.The strength of clinical associations was evaluated via ROC analysis, and independent relationships were assessed using multivariable logistic regression models adjusting for age and HbA1c.
Results
Serum Fibulin-5 and SBP-1 levels were significantly elevated in the NPDR group compared to all other groups (p
Zitieren
APA
Arslan, M. S., Katar, M., & Sener, E. (2026). Serum Fibulin-5, VEGF-C, and selenium-binding protein-1 levels across stages of diabetic retinopathy: An observational study on pathophysiological associations. International Journal of Medical Biochemistry, 111-116. https://doi.org/10.14744/ijmb.2026.87360
Vancouver
Arslan MS, Katar M, Sener E. Serum Fibulin-5, VEGF-C, and selenium-binding protein-1 levels across stages of diabetic retinopathy: An observational study on pathophysiological associations. International Journal of Medical Biochemistry. 2026:111-116. doi:10.14744/ijmb.2026.87360
BibTeX
@article{Arslan2026,
author = {Arslan, Muhammed Selman and Katar, Muzaffer and Sener, Ender},
title = {Serum Fibulin-5, VEGF-C, and selenium-binding protein-1 levels across stages of diabetic retinopathy: An observational study on pathophysiological associations},
journal = {International Journal of Medical Biochemistry},
year = {2026},
pages = {111--116},
doi = {10.14744/ijmb.2026.87360}
}
EUVIMED